Cargando…
Gene Editing/Gene Therapies: BIOREACTOR RECOMBINANT PRODUCTION OF SARS-COV-2 VIRUS ANTIGENS IN CHO CELL CLONES BY USING NEW UCOE LENTIVIRAL VECTOR SYSTEM
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society for Cell & Gene Therapy. Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171031/ http://dx.doi.org/10.1016/S1465-3249(23)00636-9 |
_version_ | 1785039345056481280 |
---|---|
author | Anakok, O.F. Kose, P. Bayindirli, K.N. |
author_facet | Anakok, O.F. Kose, P. Bayindirli, K.N. |
author_sort | Anakok, O.F. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10171031 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | International Society for Cell & Gene Therapy. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101710312023-05-10 Gene Editing/Gene Therapies: BIOREACTOR RECOMBINANT PRODUCTION OF SARS-COV-2 VIRUS ANTIGENS IN CHO CELL CLONES BY USING NEW UCOE LENTIVIRAL VECTOR SYSTEM Anakok, O.F. Kose, P. Bayindirli, K.N. Cytotherapy POSTER ABSTRACTS: Gene Editing/Gene Therapies International Society for Cell & Gene Therapy. Published by Elsevier Inc. 2023-05 2023-05-10 /pmc/articles/PMC10171031/ http://dx.doi.org/10.1016/S1465-3249(23)00636-9 Text en Copyright © 2023 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | POSTER ABSTRACTS: Gene Editing/Gene Therapies Anakok, O.F. Kose, P. Bayindirli, K.N. Gene Editing/Gene Therapies: BIOREACTOR RECOMBINANT PRODUCTION OF SARS-COV-2 VIRUS ANTIGENS IN CHO CELL CLONES BY USING NEW UCOE LENTIVIRAL VECTOR SYSTEM |
title | Gene Editing/Gene Therapies: BIOREACTOR RECOMBINANT PRODUCTION OF SARS-COV-2 VIRUS ANTIGENS IN CHO CELL CLONES BY USING NEW UCOE LENTIVIRAL VECTOR SYSTEM |
title_full | Gene Editing/Gene Therapies: BIOREACTOR RECOMBINANT PRODUCTION OF SARS-COV-2 VIRUS ANTIGENS IN CHO CELL CLONES BY USING NEW UCOE LENTIVIRAL VECTOR SYSTEM |
title_fullStr | Gene Editing/Gene Therapies: BIOREACTOR RECOMBINANT PRODUCTION OF SARS-COV-2 VIRUS ANTIGENS IN CHO CELL CLONES BY USING NEW UCOE LENTIVIRAL VECTOR SYSTEM |
title_full_unstemmed | Gene Editing/Gene Therapies: BIOREACTOR RECOMBINANT PRODUCTION OF SARS-COV-2 VIRUS ANTIGENS IN CHO CELL CLONES BY USING NEW UCOE LENTIVIRAL VECTOR SYSTEM |
title_short | Gene Editing/Gene Therapies: BIOREACTOR RECOMBINANT PRODUCTION OF SARS-COV-2 VIRUS ANTIGENS IN CHO CELL CLONES BY USING NEW UCOE LENTIVIRAL VECTOR SYSTEM |
title_sort | gene editing/gene therapies: bioreactor recombinant production of sars-cov-2 virus antigens in cho cell clones by using new ucoe lentiviral vector system |
topic | POSTER ABSTRACTS: Gene Editing/Gene Therapies |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171031/ http://dx.doi.org/10.1016/S1465-3249(23)00636-9 |
work_keys_str_mv | AT anakokof geneeditinggenetherapiesbioreactorrecombinantproductionofsarscov2virusantigensinchocellclonesbyusingnewucoelentiviralvectorsystem AT kosep geneeditinggenetherapiesbioreactorrecombinantproductionofsarscov2virusantigensinchocellclonesbyusingnewucoelentiviralvectorsystem AT bayindirlikn geneeditinggenetherapiesbioreactorrecombinantproductionofsarscov2virusantigensinchocellclonesbyusingnewucoelentiviralvectorsystem |